Skip to main content

Bodhi Tree Biotechnology Inc

corporate_fare Company Profile

Bodhi Tree Biotechnology Inc

BDTB·OTC·Trade & Services·CIK 0002041531

Bodhi Tree Biotechnology Inc. is an early-stage consulting company incorporated in Delaware on December 12, 2023. The company focuses on providing plant-based menu design, recipe development, and vegetarian diet consulting services from its executive office in Danville, California. Its services align with consumer interest in flexitarian, vegetarian, and organic lifestyles, addressing the demand for healthier recipe options and sustainable dietary habits. The company's strategy involves introducing vegetarian lifestyle attributes and connecting with consumers who value nutritious, sustainably sourced, and plant-based meals and recipes. It focuses on design and product development, including creating distinctive flavor profiles for vegetarian consumers, and developing new recipes and menus to meet market trends and demand for healthy plant-based options. Bodhi Tree Biotechnology also offers dietary consulting to help customers integrate vegetarian principles into their daily nutrition. The company's President and CEO, Xiaohang Wang, has over 13 years of experience in the health products industry, and its CFO, Juan Ye, has served in that capacity at another company since 2019. As an early-stage company, its operations are limited, and it is not currently subject to environmental regulations. Its vegetarian menu and recipe design services are provided on a project-by-project basis, focusing on plant-based menus and vegetarian recipes that meet customer preferences for healthier and more sustainable food options.

Bodhi Tree Biotechnology Inc (OTC:BDTB) is a publicly traded company in the Trade & Services sector. Wiseek monitors BDTB SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Bodhi Tree Biotechnology Reports Critical Liquidity, Material Control Weaknesses, and Extreme Customer Concentration

Financial Snapshot

Fiscal year ended September 30, 2025
Revenue
$17K
Net Income
-$149.67K
Diluted EPS
-$0.01
Op. Cash Flow
-$150.17K
Operating Income
-$147.62K
Cash & Equivalents
$109.4K
Debt / Equity
0.00×
Net Margin
-8.80×
Shares Outstanding
25.44M sh
Source: 10-K · filed 2025-12-29 · accession 0001829126-25-010312
Browse all tickers starting with B →
$0.20
52-week range · as of 2026-05-14 $0.06 – $0.20
Volume
30K (1.0× avg)
3-mo avg 30K
Live data · 2026-06-28 11:03 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BDTB - Latest Insights

BDTB
May 14, 2026, 10:26 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.200
Real-time Price: $0.200 info
Change: $0 (0%) info
Market Cap: N/A info